Thromboelastography Might Be More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19 - 21/05/21
Doi : 10.1016/j.jamcollsurg.2021.03.005
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
| Disclosure Information: Nothing to disclose. |
|
| Disclosures Outside the Scope of this Work: Dr Brubaker is supported by the NIH/NHLBI T32 HL139425; Dr Trautner is supported in part by the Center for Innovations in Quality, Effectiveness and Safety (CIN 13-413) at the Michael E DeBakey VA Medical Center. Dr Cruz is supported in part by the Center for Translational Research on Inflammatory Disease (CTRID), Michael E DeBakey VA Medical Center, and is the founder of A2 Therapeutics. |
|
| Disclaimer: The contents of this letter do not represent the views of the Department of Veterans Affairs or the US Government. |
© 2021
American College of Surgeons. Tous droits réservés.
Vol 232 - N° 6
P. 1021-1022 - juin 2021 Retour au numéro
Article précédent
- Resident Education in Biliary Operation: Beyond Laparoscopic Cholecystectomy
- Alexander R. Cortez, John R. Potts
- Outcomes of Margin Status on Survival in Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Therapy
- Ashish Swami, Vaibhav Kumar Varshney
Bienvenue sur EM-consulte, la référence des professionnels de santé.